WesBanco Bank’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.31M Sell
5,984
-5,484
-48% -$1.16M 0.06% 230
2020
Q2
$2.19M Sell
11,468
-15,626
-58% -$2.74M 0.11% 160
2020
Q1
$4.2M Sell
27,094
-19,395
-42% -$2.26M 0.24% 106
2019
Q4
$3.89M Hold
46,489
– – 0.18% 128
2019
Q3
$3.15M Buy
46,489
+3,657
+9% +$241K 0.16% 130
2019
Q2
$2.84M Buy
42,832
+21,841
+104% +$1.27M 0.14% 139
2019
Q1
$1.17M Buy
20,991
+6,342
+43% +$387K 0.06% 240
2018
Q4
$726K Buy
14,649
+3,614
+33% +$221K 0.04% 260
2018
Q3
$953K Buy
+11,035
New +$786K 0.05% 281

Other funds holding TDOC

WesBanco Bank's TDOC Position: Q3 2020 in Review

WesBanco Bank reduced its Teladoc Health (TDOC) stake by 48% in Q3 2020, selling an estimated $1.16M and leaving 5,984 shares worth $1.31M. The position accounts for 0.06% of the portfolio, ranked #230.

WesBanco Bank first reported a position in TDOC in Q3 2018 and has held it in 9 quarters since. The position peaked at $4.2M in Q1 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • WesBanco Bank held 5,984 shares of Teladoc Health worth $1.31M as of Q3 2020.
  • WesBanco Bank sold 5,484 Teladoc Health shares in Q3 2020, an estimated $1.16M.
  • Teladoc Health made up 0.06% of WesBanco Bank's portfolio in Q3 2020, its #230 holding.
  • WesBanco Bank first reported a position in Teladoc Health in Q3 2018 and has held it in 9 quarters since.
  • WesBanco Bank's Teladoc Health position peaked at $4.2M in Q1 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on WesBanco Bank's 13F filing for Q3 2020, filed 13 Nov 2020.